Papers 1–10 of
44
by Melvin E Andersen
- L Dong, Z Jiang, L Yang, F Hu, W Zheng, P Xue, S Jiang, ME Andersen, G He, MJC Crabbe, and W Qu. The genotoxic potential of mixed nitrosamines in drinking water involves oxidative stress and Nrf2 activation. J Hazard Mater 426 : 128010 (Mar 15, 2022). [abstract] [pubmed]
- MB Black, ME Andersen, SN Pendse, SJ Borghoff, M Streicker, and PD McMullen. RNA-sequencing (transcriptomic) data collected in liver and lung of male and female B6C3F1 mice exposed to various dose levels of 4-methylimidazole for 2, 5, or 28 days. Data Brief 38 : 107420 (Oct 23, 2021). [abstract] [pubmed]
- SJ Borghoff, SE Fitch, MB Black, PD McMullen, ME Andersen, and GA Chappell. A systematic approach to evaluate plausible modes of actions for mouse lung tumors in mice exposed to 4-methylimidozole. Regul Toxicol Pharmacol 124 : 104977 (Aug 24, 2021). [abstract] [pubmed]
- ME Andersen, P Mallick, HJ Clewell, M Yoon, GW Olsen, and MP Longnecker. Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures. Environ Res 197 : 111183 (Apr 20, 2021). [abstract] [pubmed]
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- PD McMullen, S Bhattacharya, CG Woods, SN Pendse, MT McBride, VY Soldatow, C Deisenroth, EL LeCluyse, RA Clewell, and ME Andersen. Identifying qualitative differences in PPARα signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods. Toxicol In Vitro 64 : 104463 (Apr 15, 2020). [abstract] [pubmed]
- P Xue, Y Hou, Z Zuo, Z Wang, S Ren, J Dong, J Fu, H Wang, ME Andersen, Q Zhang, Y Xu, and J Pi. Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARγ expression. Redox Biol 30 : 101414 (Feb 28, 2020). [abstract] [pubmed]
- L Li, J Fu, D Liu, J Sun, Y Hou, C Chen, J Shao, L Wang, X Wang, R Zhao, H Wang, ME Andersen, Q Zhang, Y Xu, and J Pi. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. Redox Biol 30 : 101412 (Feb 23, 2020). [abstract] [pubmed]
- R Nault, B Bals, F Teymouri, MB Black, ME Andersen, PD McMullen, S Krishnan, N Kuravadi, N Paul, S Kumar, K Kannan, KC Jayachandra, L Alagappan, BD Patel, KT Bogen, BB Gollapudi, JE Klaunig, TR Zacharewski, and V Bringi. A toxicogenomic approach for the risk assessment of the food contaminant acetamide. Toxicol Appl Pharmacol 388 : 114872 (Feb 1, 2020). [abstract] [pubmed]
- D Krewski, MG Tyshenko, K Krishnan, T Hartung, K Boekelheide, JF Wambaugh, D Jones, M Whelan, R Thomas, C Yauk, T Barton-Maclaren, I Cote, and ME Andersen. Toxicity testing in the 21st century: progress in the past decade and future perspectives. Arch Toxicol 94 (1) : 1-58 (Jan 17, 2020). [abstract] [pubmed]